JSJulian Spears

Julian Spears

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Julian Spears has a total of 292 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Impact of middle meningeal artery embolization timing on chronic subdural hematoma resolution and functional outcomes

    by Bluyé DeMessie, Muhammed Amir Essibayi, Hamza Adel Salim, Alireza Karandish, Nathan Farkas, Deepak Khatri, Neil Haranhalli, Amanda Baker, Richard Zampolin, Allan L. Brook, et al.


  • Automated perfusion imaging did not improve reliability of ASPECTS or collateral score in late-window large vessel occlusion stroke

    by Anass Benomar, Robert Fahed, Abdelsimar Tan Omar, Christine Hawkes, Eef J Hendriks, Clare A Enriquez, Muneer Eesa, Grant Stotts, Hubert Lee, Shashank Nagendra, et al.

    Background: The Alberta Stroke Program Early CT Score (ASPECTS) and CT angiography (CTA) Collateral Score (CS) are routinely used to estimate ischemic core burden and collateral status in acute ischemic stroke due to large vessel occlusion, but suffer from limited reliability. Whether automated CT perfusion (CTP) maps improve scoring consistency remains unclear. Objectives: To assess the reliability of these scores on non-contrast computed tomography (NCCT) and CTA among numerous raters, with and without access to automated perfusion maps, and their correlations with endovascular thrombectomy (EVT) decisions. Methods: Twenty-nine clinicians independently rated 60 imaging cases from 30 late-window stroke patients with large vessel occlusion, each presented twice: once using NCCT and CTA alone (‘non-CTP cases’), and once with the addition of perfusion maps (‘CTP cases’). Twenty-eight raters (97%) completed the survey twice. Inter- and intra-reliability was assessed using Gwet’s AC1/2 coefficients (κ G ). Correlations with EVT decisions were evaluated using Cramer V. Results: Inter-rater reliability for ASPECTS was substantial and similar between non-CTP (κ G = 0.65, 95% CI: 0.53 to 0.78) and CTP cases (κ G = 0.64, 95% CI: 0.51 to 0.77). CS showed an almost perfect reliability in both scenarios (κ G = 0.82 and 0.83). Intra-rater agreement was at least substantial. Dichotomizing ASPECTS as 0-2/3-10 improved reliability to almost perfect. ASPECTS strongly correlated with EVT decisions (V=0.80), whereas CS showed moderate correlation (V=0.56), both remaining similar with the addition of CTP (V=0.75 and 0.54, respectively). Conclusion: Automated perfusion imaging did not improve the reliability of ASPECTS or CS. Strong reliability was achieved with NCCT and CTA alone.

  • Follow-up imaging characteristics of a Novel Braided Stent (BosSTENT™) in treating transverse sinus stenosis related to venous congestion and/or pulsatile tinnitus

    by Vitor Mendes Pereira, Rodrigo Fellipe Rodrigues, Arturo Consoli, Kevin Janot, Aruma Jimenez, Jose Danilo Bengzon Diestro, Julian Spears, Irene Vanek, Eileen Liu, Nicole Cancelliere

    Background: Transverse sinus stenosis (TSS) is increasingly recognized as a key contributor to pulsatile tinnitus (PT) and cerebral venous congestion (CVC), including idiopathic intracranial hypertension (IIH). While venous stenting has shown promising clinical outcomes, long-term imaging data on dedicated braided stents remain limited. Objective: To report the clinical and imaging outcomes of the BosSTENT™, a novel self-expanding braided stent, in patients with symptomatic TSS. Methods: This retrospective study included 27 consecutive patients treated at a single institution between December 2022 and December 2024. All patients presented with PT, with or without chronic headaches or signs of intracranial hypertension. Patients underwent BosSTENT™ deployment and were followed clinically and radiologically for up to 2 years. Outcomes included symptom resolution, procedural safety, and long-term stent integrity based on structured imaging protocols. Results: Of the 27 patients (96.3% female, mean age 41.4 years), 26 have long-term follow-up, 96.2% achieved overall improvement of PT and 84.6% experienced complete or significant improvement in headaches. One patient experienced a fatal subdural hematoma unrelated to device performance, and two patients had femoral access site complications. Imaging follow up confirmed persistent stent patency and structural integrity in all cases, with no instances of thrombus, in-stent stenosis, migration, fracture, or adjacent stenosis. Conclusion: The BosSTENT™ demonstrates favorable long-term safety and performance in the treatment of symptomatic transverse sinus stenosis. These findings support its role as a dedicated device for venous sinus stenting, particularly in patients with pulsatile tinnitus and intracranial hypertension.


  • Impact of Image Latency and Frame Rate on Simulated Remote Robotic-Assisted Neurovascular Procedures

    by Arturo Consoli, Guillaume Charbonnier, Thais Baena Moura, Khaled Gaber, Alexander O’nEill, Thomas R. Marotta, Julian Spears, Eileen Liu, Nicole Mariantonia Cancelliere, Vitor Mendes Pereira

    The implementation of remote procedures represents the ultimate goal of the robotic development in the neurovascular field. Studies from remote cardiac interventions established a maximum latency threshold of 400 ms, however, no data are available for neurovascular procedures. The aim of this study was to define the maximum acceptable latency and minimum refreshment frame rate (RFR) for neuroendovascular procedures in a simulated remote setting. Using a virtual simulator and an endovascular robotic arm, 7 operators performed 8 simulated aneurysm and stroke treatment interventions (4 manually and 4 robotic-assisted), during which video display of the intervention was randomly altered with different latencies (100, 250, 450, 600, 800 ms) and RFR (10, 15, 25, 30 frames per second [fps]). Operators rated the acceptability of each latency and RFR by using a modified acceptability score (mAS) and an independent observer recorded the number of dangerous uncontrolled movement (DUMs). Maximum acceptable latency (defined as a minimum mAS of 85%) was defined at 100 ms for manually performed procedures and at 250 ms by using robotic-assistance, whereas minimum acceptable RFR was defined at 15 fps. A total of 55 intracranial DUMs were recorded, most of which occurred at latencies ≥450 ms (49/51) and with RFRs of 10 fps (4/4). Time intervals were shorter for manual procedures, although not significantly, and for experienced operators. Latency during simulated neurovascular interventions influences operator performance, judgment, and confidence and maximum thresholds (250 ms) seem to be lower than those previously reported from remote cardiac interventions. In this experimental setting, RFR seemed to have a lower impact in terms of acceptance rates. Latency and RFR represent relevant parameters to define and monitor in remote environments to maximize safety.


  • Baseline predictors of poor clinical outcome despite recanalization of distal middle cerebral artery occlusions

    by Imene Chafai, Hamza Salim, Basel Musmar, Nimer Adeeb, Vivek Yedavalli, Kareem ElNaamani, Nils Henninger, Simona Nedelcu, Sri Hari Sundararajan, Anna Luisa Kühn, et al.

    Objective: Mechanical thrombectomy (MT) is well-established for the treatment of acute ischemic stroke (AIS) from large vessel occlusion (LVO), with growing data supporting the expansion to distal and medium vessel occlusions (DMVO). Despite successful recanalization in DMVO, certain patients still experience poor long-term clinical outcomes, prompting our study to comprehensively explore pre-MT factors influencing outcome despite excellent recanalization (final modified Thrombolysis in Cerebral Infarction [mTICI] score ≥2c). Methods: We retrospectively examined data from patients who consecutively underwent MT for a primary middle cerebral artery (MCA) DMVO across 37 centers in North America, Asia, and Europe. We identified baseline clinical and imaging factors associated with poor clinical outcome (defined as a modified Rankin Scale [mRS] score of 3–6) at 3 months, despite excellent recanalization using a multivariable model. Results: Between September 2017 and July 2021, 623 patients achieved mTICI > 2b and they were included in our study. Among them, 198 (32%) experienced a poor clinical outcome (mRS 3–6). Predictors of poor clinical outcome included higher age (OR 1.05 [1.03–1.07], p < 0.001), higher NIHSS at admission (OR 1.12 [1.08–1.15], p < 0.001), higher baseline mRS (OR 1.77 [0.96–3.26], p = 0.067), and diabetes (OR 1.59 [1.01–2.48], p = 0.044). Higher ASPECTS was associated with a decreased risk of poor clinical outcome (OR 0.82 [0.71–0.94], p = 0.006). Conclusion: Older age, diabetes, higher baseline mRS, and NIHSS were associated with poor clinical outcome in MCA DMVO despite excellent recanalization. Conversely, a higher ASPECTS decreased the probability of such an outcome.


  • Open Access

    Perspectives on Remote Robotic-Assisted Stroke Treatment: A Commentary Paper

    by Arturo Consoli, Nicole Mariantonia Cancelliere, Guillaume Charbonnier, Julian Spears, Thomas R. Marotta, Vitor Mendes Pereira

    SUMMARY: The proved feasibility of robotic-assisted endovascular treatment of intracranial aneurysms has stimulated the idea of a potential application of remote robotics for the treatment of acute ischemic stroke. The possibility of developing a more advanced remote-controlled robotic system capable of performing a complete mechanical thrombectomy procedure would help bridge the health care gap of lack of technical expertise in isolated areas. This possibility could allow a more equitable access to mechanical thrombectomy to a larger number of patients and be a breakthrough for acute ischemic stroke care worldwide. Many aspects around the technical, human, financial, and regulatory requirements should be discussed to implement remote robotic-assisted procedures. In this State of Practice article, we aimed to outline the major challenges that must be considered, as well as proposed solutions. However, different solutions may be applied in different health care systems on the basis of the availability of human and financial resources.


  • Learning Curve for Flow Diversion of Posterior Circulation Aneurysms: A Long-Term International Multicenter Cohort Study

    by N. Adeeb, M. Dibas, C.J. Griessenauer, H.H. Cuellar, M.M. Salem, S. Xiang, A. Enriquez-Marulanda, T. Hong, H. Zhang, P. Taussky, et al.

    BACKGROUND AND PURPOSE: Flow diversion has gradually become a standard treatment for intracranial aneurysms of the anterior circulation. Recently, the off-label use of the flow diverters to treat posterior circulation aneurysms has also increased despite initial concerns of rupture and the suboptimal results. This study aimed to explore the change in complication rates and treatment outcomes across time for posterior circulation aneurysms treated using flow diversion and to further evaluate the mechanisms and variables that could potentially explain the change and outcomes. MATERIALS AND METHODS: A retrospective review using a standardized data set at multiple international academic institutions was performed to identify patients with ruptured and unruptured posterior circulation aneurysms treated with flow diversion during a decade spanning January 2011 to January 2020. This period was then categorized into 4 intervals. RESULTS: A total of 378 procedures were performed during the study period. Across time, there was an increasing tendency to treat more vertebral artery and fewer large vertebrobasilar aneurysms (P = .05). Moreover, interventionalists have been increasingly using fewer overlapping flow diverters per aneurysm (P = .07). There was a trend toward a decrease in the rate of thromboembolic complications from 15.8% in 2011–13 to 8.9% in 2018–19 (P = .34). CONCLUSIONS: This multicenter experience revealed a trend toward treating fewer basilar aneurysms, smaller aneurysms, and increased usage of a single flow diverter, leading to a decrease in the rate of thromboembolic and hemorrhagic complications.


  • The Woven EndoBridge (WEB) Device for the Treatment of Intracranial Aneurysms: Ten Years of Lessons Learned and Adjustments in Practice from the WorldWideWEB Consortium

    by Adam A. Dmytriw, Mahmoud Dibas, Sherief Ghozy, Nimer Adeeb, Jose Danilo Bengzon Diestro, Kevin Phan, Hugo H. Cuellar-Saenz, Ahmad Sweid, Sovann V. Lay, Adrien Guenego, et al.

    Several studies have shown promising outcomes of the Woven EndoBridge (WEB) device for the treatment of wide-necked intracranial bifurcation aneurysms. This is a multicenter study attempts to explore the changes in trends and treatment outcomes over time for WEB embolization of intracranial aneurysms. The WorldWideWEB consortium is a retrospective multicenter collaboration of data from international centers spanning from January 2011 and June 2021, with no limitations on aneurysm location or rupture status. Both bifurcation and sidewall aneurysms were included. These patients were stratified based on treatment year into five treatment intervals: 2011–2015 (N = 66), 2016–2017 (N = 77), 2018 (N = 66), 2019 (N = 300), and 2020–2021 (N = 173). Patient characteristics and angiographic and clinical outcomes were compared between these time intervals. This study comprised 671 patients (median age 61.4 years; 71.2% female) with 682 intracranial aneurysms. Over time, we observed an increasing tendency to treat patients presenting with ruptured aneurysms and aneurysms with smaller neck, diameter, and dome widths. Furthermore, we observed a trend towards more off-label use of the WEB for sidewall aneurysms and increased adoption of transradial access for WEB deployment. Moreover, the proportion of patients with adequate WEB occlusion immediately and at last follow-up was significantly higher in more recent year cohorts, as well as lower rates of compaction and retreatment. Mortality and complications did not differ over time. This learning curve study suggests improved experience using the WEB for the treatment of intracranial aneurysms and has yielded higher rates of adequate occlusion over time.


  • Do Outcomes between Women and Men Differ after Endovascular Thrombectomy? A Meta-analysis

    by A.A. Dmytriw, J.C. Ku, V.X.D. Yang, N. Hui, K. Uchida, T. Morimoto, J. Spears, T.R. Marotta, J.D.B. Diestro

    BACKGROUND: Research on the presence of sex-based differences in the outcomes of patients undergoing endovascular thrombectomy for acute ischemic stroke has reached differing conclusions. PURPOSE: This review aimed to determine whether sex influences the outcome of patients with large-vessel occlusion stroke undergoing endovascular thrombectomy. STUDY SELECTION: We performed a systematic review and meta-analysis of endovascular thrombectomy studies with either stratified cohort outcomes according to sex (females versus males) or effect size reported for the consequence of sex versus outcomes. We included 33 articles with 7335 patients. DATA ANALYSIS: We pooled ORs for the 90-day mRS score, 90-day mortality, symptomatic intracranial hemorrhage, and recanalization. DATA SYNTHESIS: Pooled 90-day good outcomes (mRS ≤ 2) were better for men than women (OR = 1.29; 95% CI, 1.09–1.53; P = <.001, I2 = 56.95%). The odds of the other outcomes, recanalization (OR = 0.94; 95% CI, 0.77–1.15; P = .38, I2 = 0%), 90-day mortality (OR = 1.11; 95% CI, 0.89–1.38; P = .093, I2 = 0%), and symptomatic intracranial hemorrhage (OR = 1.40; 95% CI, 0.99–1.99; P = .069, I2 = 0%) were comparable between men and women. LIMITATIONS: Moderate heterogeneity was found. Most studies included were retrospective in nature. In addition, the randomized trials included were not specifically designed to compare outcomes between sexes. CONCLUSIONS: Women undergoing endovascular thrombectomy for large-vessel occlusion have inferior 90-day clinical outcomes. Sex-specific outcomes should be investigated further in future trials as well as pathophysiologic studies.


  • Open Access

    Mechanical thrombectomy after intravenous thrombolysis for acute ischaemic stroke

    by Jetan H Badhiwala, Farshad Nassiri, Abhaya V Kulkarni, Julian Spears, Saleh A Almenawer